biotech / news / / GlobeNewswire
BioNTech has authorized a new share repurchase program.
BioNTech has authorized a new share repurchase program of up to $1.0 billion in ADSs.
KEY POINTS
- The share buyback program will be active until and including May 6, 2027.
- BioNTech plans to use repurchased ADSs to satisfy obligations in the ordinary course of business.
- Share repurchases will be funded from existing cash resources and focus on price-efficient deployment.
COMPANIES
Summarized by Newsio from GlobeNewswire. How we summarize →